Mitali Pandey
Vancouver, BC V6T1Z3, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The "Ins and Outs" of Prostate Specific Membrane Antigen (PSMA) as Specific Target in Prostate Cancer Therapy.
Journal: Advances in experimental medicine and biology
Published: April 24, 2023
Inhibition of Scavenger Receptor Class B Type 1 (SR-B1) Expression and Activity as a Potential Novel Target to Disrupt Cholesterol Availability in Castration-Resistant Prostate Cancer.
Journal: Pharmaceutics
Published: June 25, 2021
Role of class I histone deacetylases in the regulation of maspin expression in prostate cancer.
Journal: Molecular carcinogenesis
Published: February 18, 2020
Differentially Expressed Genes and Molecular Pathways in an Autochthonous Mouse Prostate Cancer Model.
Journal: Frontiers in genetics
Published: October 26, 2018
The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancer.
Journal: Molecular cancer therapeutics
Published: October 01, 2014
TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling.
Journal: International journal of cancer
Published: January 28, 2013
Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1.
Journal: Molecular carcinogenesis
Published: February 24, 2012
Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: February 04, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026